<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2015092716516N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2015-11-25</date_registration>
      <primary_sponsor>Vice Chancellor for research of lorestan University of Medical Sciences</primary_sponsor>
      <public_title>The Comparison of inhaled  and  intravenous anesthesia on depth of anesthesia and hemodynamic changing in   Cholecystectomy Laparoscopic.</public_title>
      <acronym></acronym>
      <scientific_title>The Comparison of inhaled  and  intravenous anesthesia on depth of anesthesia and hemodynamic changing in   Cholecystectomy Laparoscopic.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2015-10-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>92</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/15432</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Other design features: Method randomization: block Randomized.</study_design>
      <phase>N/A</phase>
      <hc_freetext>General anesthesia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: In the operating room patients  catheterized and intravenous fluids injected .Prodrug is contains 2 ml narcotic sufentanil and 2 mg midazolam.Induction of anesthesia is done by sodium thiopental and atracurium, Then intubation is performed,In this group (Group T), maintenance of anesthesia perform with propofol 100 mg per kg of body weight per minute.&#13;
Manufacturer: pharmaceutical company of dongkook, Manufactured by country of  Korea. Intervention 2: Control group: In the operating room patients  catheterized and intravenous fluids injected .Prodrug is contains 2 ml narcotic sufentanil and 2 mg midazolam.Induction of anesthesia is done by sodium thiopental and atracurium, Then intubation is performed,In this group (Group v), maintenance of anesthesia perform withwith Sevoflurane 1.2%.          &#13;
Manufacturer: pharmaceutical company of BAXTER, Manufactured by country of GUAYAMA.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farzad Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Lorestan, Khorramabad, Lorestan University of Medical Sciences Research Department</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>381251698</zip>
        <telephone>+98 66 3322 3004</telephone>
        <email>farzad871410053@yahoo.com</email>
        <affiliation>Deputy of Research, Lorestan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>S. Nadri doctor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Lorestan, Khorramabad, Lorestan Medical Sciences University Research Assistant</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>381251698</zip>
        <telephone>+98 66 3322 3004</telephone>
        <email>dr.s.nadri@gmail.com</email>
        <affiliation>Deputy of Research, Lorestan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria:All patients 20 to 40 years undergoing laparoscopic cholecystectomy referred to Shohada hospital in Khorramabad in the second half of 1394.&#13;
Exclusion criteria:Lack of consent to participate in research projects, heart problems, allergies to eggs, a history of sensitivity to anesthesia, conversion laparoscopic surgery to open surgery, cholecystectomy, high blood pressure, history of diabetes.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K80-K87</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Disorders of gallbladder, biliary tract and pancreas</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: In the operating room patients  catheterized and intravenous fluids injected .Prodrug is contains 2 ml narcotic sufentanil and 2 mg midazolam.Induction of anesthesia is done by sodium thiopental and atracurium, Then intubation is performed,In this group (Group T), maintenance of anesthesia perform with propofol 100 mg per kg of body weight per minute.&#13;
Manufacturer: pharmaceutical company of dongkook, Manufactured by country of  Korea</i_keyword>
      <i_keyword>Control group: In the operating room patients  catheterized and intravenous fluids injected .Prodrug is contains 2 ml narcotic sufentanil and 2 mg midazolam.Induction of anesthesia is done by sodium thiopental and atracurium, Then intubation is performed,In this group (Group v), maintenance of anesthesia perform withwith Sevoflurane 1.2%.          &#13;
Manufacturer: pharmaceutical company of BAXTER, Manufactured by country of GUAYAMA</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Blood pressure. Timepoint: Before induction of anesthesia, after premedication injection, after induction of anesthesia, after intubation, during surgery four times, after extubation،And with an interval of every 15 minutes. Method of measurement: Millimeters of mercury using a sphygmomanometer.</prim_outcome>
      <prim_outcome>Heart rate. Timepoint: Before induction of anesthesia, after premedication injection, after induction of anesthesia, after intubation, during surgery four times, after extubation،؛And with an interval of every 15 minutes. Method of measurement: Depending on the number of beats per minute monitoring device.</prim_outcome>
      <prim_outcome>Depth of Anesthesia. Timepoint: Before induction of anesthesia, after premedication injection, after induction of anesthesia, after intubation, during surgery four times, after extubation،And with an interval of every 15 minutes. Method of measurement: Based on the electrical brain waves and by BIS device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for research of lorestan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2015-09-22</approval_date>
        <contact_name>Ethics Committee of Lorestan University of Medical Sciences</contact_name>
        <contact_address>Lorestan،Khorramabad،Lorestan University of Medical Sciences Khorramabad  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
